Treating insulin resistance: future prospects

Area of Science:

• Metabolic research
• Pharmacology
• Molecular biology

Background:

• Insulin resistance stems from defects in insulin receptor and post-receptor signaling pathways.
• These defects impair crucial metabolic and vascular functions.
• Numerous potential therapeutic targets and compounds have been identified.

Purpose of the Study:

• To review current therapeutic strategies for insulin resistance.
• To highlight novel approaches targeting insulin receptor and downstream signaling.
• To discuss the potential for broad-spectrum therapeutic interventions.

Main Methods:

• Review of existing literature on insulin resistance mechanisms and treatments.
• Analysis of studies demonstrating therapeutic potential of various compounds.
• Exploration of signaling pathway modulation strategies.

Main Results:

• Non-peptide insulin mimetics show promise through direct insulin receptor activation.
• Agents enhancing insulin receptor tyrosine kinase activity, like phosphatase inhibitors, potentiate insulin action.
• Modulating phosphatidylinositol 3-kinase and addressing signaling defects from cytokines, hormones, and metabolic factors are viable approaches.

Conclusions:

• Multiple therapeutic avenues exist for insulin resistance, targeting various signaling defects.
• Compounds like hormones, enzymes, minerals, and co-activators exhibit insulin-sensitizing potential.
• The multifaceted nature of insulin resistance allows for simultaneous therapeutic interventions across metabolic and cardiovascular fronts.